NOT-AI-24-053 Notice of Special Interest (NOSI): Discovery and Development of Oral Small-molecule Direct-acting Antivirals Targeting Viruses of Pandemic Potential.

Application due dates on or after October 5, 2024, and subsequent receipt dates through July 16, 2027

Funder: NIH National Institute of Allergy and Infectious Diseases (NIAID)

This Notice of Special Interest (NOSI) invites applications focused on the preclinical discovery, evaluation and development of oral direct-acting small molecule therapeutics targeting selected viruses of pandemic potential. The ultimate goal of this NOSI is to build a more robust pipeline of candidate antiviral drugs suitable for widespread use in the community in future outbreaks and/or pandemics.

 

Learn More Contact OSR to Apply

Topics: Applied Research, Biomarkers, Immunology, Host Factors, Host Response, Virology, Viral Interactome, Viral Proteins, Virus Biology, Virus Evolution, Virus Factors, Vaccine Development, Vaccine Efficacy, Vaccine Reliability, Vaccine Scalability, Vaccines, Treatments, Immunological Response Targets, Treatment Efficacy, Treatment Reliability, Treatment Scalability, Drugs, Drug Development, Drug Repurposing, Drug Targets, Immunological Response Targets, Anti-viral Targets